Preclinical evaluation of singlet oxygen‐cleavable prodrugs in combination with protoporphyrin IX‐photodynamic therapy in an orthotopic rat model of non‐muscle‐invasive bladder cancer
Photochemistry and Photobiology · 2024
DOI: 10.1111/php.13838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Photochemistry and Photobiology, 2024. Verfasst von Kazi Md Mahabubur Rahman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, New York, USA. Hauptthemen laut MEDLINE: Prodrugs, Urinary Bladder Neoplasms, Protoporphyrins, Photochemotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Institute of Health, U.S. Department of Defense.
Abstract (Originalsprache)
Photodynamic therapy (PDT) initially employed red light, which caused some patients to experience permanent bladder contractions. PDT using the FDA‐approved drug hexaminolevulinate (HAL), which produces protoporphyrin IX (PpIX) in the tumor, showed some promise but has low efficacy in treating non‐muscle‐invasive bladder cancer (NMIBC). We developed singlet oxygen‐activatable prodrugs of two anticancer drugs, paclitaxel and mitomycin C, to enhance the antitumor effect of PpIX‐PDT without producing systemic side effects, by promoting only local release of the active chemotherapeutic agent. Orthotopic NMIBC model was used to compare the efficacy of prodrugs only, PpIX‐PDT, and prodrugs + PpIX‐PDT. 532 nm laser with a total power of 50 mW for 20 min (60 J, single treatment) was used with HAL and prodrugs. Histology and microscopic methods with image analysis were used to evaluate the tumor staging, antitumor efficacy, and local toxicity. Prodrug + PpIX‐PDT produced superior antitumor efficacy than PpIX‐PDT alone with statistical significance. Both PpIX‐PDT alone and combination therapy resulted in mild damage to the bladder epithelium in the normal bladder area with no apparent damage to the muscle layer. Overall, SO‐cleavable prodrugs improved the antitumor efficacy of PpIX‐PDT without causing severe and permanent damage to the bladder muscle layer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, New York, USA.
- Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
ORCID-Profile: Kazi Md Mahabubur Rahman, Barbara A Foster, Youngjae You
Förderung
- National Institute of Health
- U.S. Department of Defense
Zitieren
APA
Rahman, K. M. M., Foster, B. A., & You, Y. (2024). Preclinical evaluation of singlet oxygen‐cleavable prodrugs in combination with protoporphyrin IX‐photodynamic therapy in an orthotopic rat model of non‐muscle‐invasive bladder cancer. Photochemistry and Photobiology. https://doi.org/10.1111/php.13838
Vancouver
Rahman KMM, Foster BA, You Y. Preclinical evaluation of singlet oxygen‐cleavable prodrugs in combination with protoporphyrin IX‐photodynamic therapy in an orthotopic rat model of non‐muscle‐invasive bladder cancer. Photochemistry and Photobiology. 2024. doi:10.1111/php.13838
BibTeX
@article{Rahman2024,
author = {Rahman, Kazi Md Mahabubur and Foster, Barbara A and You, Youngjae},
title = {Preclinical evaluation of singlet oxygen‐cleavable prodrugs in combination with protoporphyrin IX‐photodynamic therapy in an orthotopic rat model of non‐muscle‐invasive bladder cancer},
journal = {Photochemistry and Photobiology},
year = {2024},
doi = {10.1111/php.13838}
}
EUVIMED